DK464483A - Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel - Google Patents

Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel Download PDF

Info

Publication number
DK464483A
DK464483A DK464483A DK464483A DK464483A DK 464483 A DK464483 A DK 464483A DK 464483 A DK464483 A DK 464483A DK 464483 A DK464483 A DK 464483A DK 464483 A DK464483 A DK 464483A
Authority
DK
Denmark
Prior art keywords
preparation
procedure
fibrinolytic agent
pharmaceutical preparation
pharmaceutical
Prior art date
Application number
DK464483A
Other languages
English (en)
Other versions
DK464483D0 (da
DK161564B (da
DK161564C (da
Inventor
Francesco Borrelli
Francesco Antonetti
Original Assignee
Serono Ist Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Ist Farm filed Critical Serono Ist Farm
Publication of DK464483D0 publication Critical patent/DK464483D0/da
Publication of DK464483A publication Critical patent/DK464483A/da
Publication of DK161564B publication Critical patent/DK161564B/da
Application granted granted Critical
Publication of DK161564C publication Critical patent/DK161564C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK464483A 1982-10-08 1983-10-07 Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase DK161564C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4924182 1982-10-08
IT49241/82A IT1189379B (it) 1982-10-08 1982-10-08 Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico

Publications (4)

Publication Number Publication Date
DK464483D0 DK464483D0 (da) 1983-10-07
DK464483A true DK464483A (da) 1984-04-09
DK161564B DK161564B (da) 1991-07-22
DK161564C DK161564C (da) 1992-01-06

Family

ID=11270058

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464483A DK161564C (da) 1982-10-08 1983-10-07 Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase

Country Status (12)

Country Link
US (1) US4568543A (da)
EP (1) EP0106812B1 (da)
JP (1) JPS5989630A (da)
AT (1) ATE44467T1 (da)
AU (1) AU559192B2 (da)
CA (1) CA1217717A (da)
DE (2) DE3380166D1 (da)
DK (1) DK161564C (da)
ES (1) ES8704736A1 (da)
IL (1) IL69938A (da)
IT (1) IT1189379B (da)
ZA (1) ZA837484B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5279824A (en) * 1988-04-14 1994-01-18 Merck Patent Gmbh Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis
ES2072424T3 (es) * 1989-01-27 1995-07-16 Immunolytics Inc Formula y metodo para el tratamiento de hipertrofias prostaticas benignas.
CA2027936C (en) 1989-10-23 2001-07-24 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
EP0794779A4 (en) * 1994-12-22 1998-04-29 Smithkline Beecham Corp FIBRINOGENIC RECEPTOR ANTAGONISTS
AU2003220115A1 (en) * 2002-05-20 2003-12-12 Board Of Regents, The University Of Texas System Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1179787A (en) * 1967-03-22 1970-01-28 Biorex Laboratories Ltd Stabilised and Potentiated Therapeutic Enzyme Compositions
US3708575A (en) * 1970-05-13 1973-01-02 Biorex Laboratories Ltd Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
US4271150A (en) * 1979-03-07 1981-06-02 Zeria-Shinyaku Kogyo Kabushiki Kaisha Urokinase preparation for oral administration

Also Published As

Publication number Publication date
DK464483D0 (da) 1983-10-07
JPS6150927B2 (da) 1986-11-06
AU1988383A (en) 1984-04-12
EP0106812B1 (en) 1989-07-12
EP0106812A3 (en) 1985-09-11
CA1217717A (en) 1987-02-10
ES526300A0 (es) 1987-05-01
IL69938A (en) 1987-09-16
DK161564B (da) 1991-07-22
US4568543A (en) 1986-02-04
JPS5989630A (ja) 1984-05-23
IT8249241A0 (it) 1982-10-08
EP0106812A2 (en) 1984-04-25
DE106812T1 (de) 1984-08-30
DE3380166D1 (en) 1989-08-17
IL69938A0 (en) 1984-01-31
IT1189379B (it) 1988-02-04
AU559192B2 (en) 1987-02-26
DK161564C (da) 1992-01-06
ZA837484B (en) 1984-06-27
IT8249241A1 (it) 1984-04-08
ATE44467T1 (de) 1989-07-15
ES8704736A1 (es) 1987-05-01

Similar Documents

Publication Publication Date Title
MY101791A (en) New benzimidazole derivatives
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
EG18379A (en) Novel pharmacological compounds
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
DK154537C (da) Hurtig-disintegrerende komprimerede laegemiddelpraeparater
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
FI812810A7 (fi) Ammoniometyyliyhdisteitä, menetelmiä niiden valmistamiseksi, näitä yhdisteitä sisältäviä farmaseuttisia valvalmisteita ja viimemainittujen käyttö.
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
DK464483D0 (da) Fremgangsmade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel
ZA773259B (en) Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects
JO1406B1 (en) Chemical compounds
AU4695879A (en) Controlled-release pharmaceutical dosage component
SE8405588D0 (sv) New compounds
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
DE3787386D1 (de) In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung.
FI850037A7 (fi) Trisyklisiä yhdisteitä, menetelmiä niidenvalmistamiseksi, tällaisia yhdisteitä sisältävät koostumukset ja niiden käyttö lääketieteessä.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ZA776142B (en) Biologically active tricyclic compounds and pharmaceutical compositions containing same
JPS53127832A (en) Antiphkogistics for oral administration containing thiaprostaglandins
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
TR22867A (tr) Birden fazla aktif bilesen ihtiva eden insektisid terkibi
FI820618A7 (fi) 7-Asyyliamido- 3-kefem-4- karboksyylihappoyhdisteet, menetelmä niiden valmistamiseksi, näitä yhdyhdisteitä sisältävät farmaseuttiset valmist eet, ja yhdisteiden käyttö
IT1178218B (it) Composti derivati dal fluorene ad attivita' antinfiammatoria, analgesica ed antipiretica e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
PUP Patent expired